Clinical Trial Update: Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. [Phase 3]

View source ↗

Summary

This update reports the Phase 3 clinical trial of BAY59-7939 (rivaroxaban) for prevention of venous thromboembolism in elective total knee replacement; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• BAY59-7939

Snippet

Sponsor: Bayer | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2012-06-13